PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 209 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $121,768,000 | -12.4% | 2,799,916 | -23.3% | 8.62% | -1.8% |
| Q1 2019 | $139,000,000 | -11.5% | 3,652,134 | 0.0% | 8.77% | -24.1% |
| Q4 2018 | $157,115,000 | -12.5% | 3,652,134 | 0.0% | 11.56% | +19.6% |
| Q3 2018 | $179,502,000 | +49.2% | 3,652,134 | -2.7% | 9.66% | +24.5% |
| Q2 2018 | $120,310,000 | +46.6% | 3,753,834 | +42.5% | 7.76% | +3.5% |
| Q1 2018 | $82,078,000 | +12.2% | 2,634,916 | +64.4% | 7.50% | +13.5% |
| Q4 2017 | $73,147,000 | +41.1% | 1,602,334 | +16.1% | 6.61% | +15.3% |
| Q3 2017 | $51,824,000 | +16.9% | 1,380,134 | +41.9% | 5.73% | +23.3% |
| Q1 2017 | $44,348,000 | +117.3% | 972,535 | +53.9% | 4.65% | +107.4% |
| Q4 2016 | $20,407,000 | – | 631,805 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 550,000 | $18,442,000 | 6.98% |
| Gagnon Advisors, LLC | 193,860 | $6,500,000 | 6.06% |
| GAGNON SECURITIES LLC | 407,159 | $13,652,000 | 4.64% |
| Spyglass Capital Management LLC | 1,190,537 | $39,919,000 | 4.51% |
| Paulson & Co. | 1,716,727 | $57,562,000 | 2.20% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,627,521 | $54,571,000 | 1.73% |
| Elk Creek Partners, LLC | 265,146 | $8,890,000 | 1.53% |
| HealthCor Management, L.P. | 887,370 | $29,754,000 | 1.27% |
| Rock Springs Capital Management LP | 900,000 | $30,177,000 | 1.25% |
| Lisanti Capital Growth, LLC | 108,679 | $3,644,000 | 1.20% |